[Federal Register Volume 84, Number 35 (Thursday, February 21, 2019)]
[Notices]
[Pages 5478-5479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02866]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Registration

ACTION: Notice of registration.

-----------------------------------------------------------------------

SUMMARY: The registrants listed below have applied for and been granted 
registration by the Drug Enforcement Administration (DEA) as importers 
of schedule I or schedule II controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be 
registered as importers of various basic classes of controlled 
substances. Information on previously published notices is listed in 
the table below. No comments or objections were submitted and no 
requests for hearing were submitted for these notices.

------------------------------------------------------------------------
            Company                    FR docket            Published
------------------------------------------------------------------------
Janssen Pharmaceuticals, Inc..  83 FR 58598...........  November 20,
                                                         2018.
Lipomed.......................  83 FR 58601...........  November 20,
                                                         2018.
Akorn, Inc....................  83 FR 60896...........  November 27,
                                                         2018.
Cambridge Isotope Laboratories  83 FR 60897...........  November 27,
                                                         2018.
GE Healthcare.................  83 FR 60899...........  November 27,
                                                         2018.
Fisher Clinical Services, Inc.  83 FR 60900...........  November 27,
                                                         2018.
------------------------------------------------------------------------


[[Page 5479]]

    The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 
958(a) and determined that the registration of the listed registrants 
to import the applicable basic classes of schedule I or II controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971. The DEA investigated each of the 
company's maintenance of effective controls against diversion by 
inspecting and testing each company's physical security systems, 
verifying each company's compliance with state and local laws, and 
reviewing each company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the DEA has granted a registration as 
an importer for schedule I or schedule II controlled substances to the 
above listed companies.

    Dated: January 29, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-02866 Filed 2-20-19; 8:45 am]
 BILLING CODE 4410-09-P